Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
10.24 USD | -5.54% | +13.40% | +12.16% |
May. 03 | Stifel Starts Phathom Pharmaceuticals With Buy Rating, $24 Price Target | MT |
Mar. 07 | Transcript : Phathom Pharmaceuticals, Inc., Q4 2023 Earnings Call, Mar 07, 2024 |
Financials (USD)
Sales 2024 * | 43.23M | Sales 2025 * | 165M | Capitalization | 634M |
---|---|---|---|---|---|
Net income 2024 * | -273M | Net income 2025 * | -229M | EV / Sales 2024 * | 10.2 x |
Net cash position 2024 * | 195M | Net cash position 2025 * | 89.8M | EV / Sales 2025 * | 3.3 x |
P/E ratio 2024 * |
-2.31
x | P/E ratio 2025 * |
-2.96
x | Employees | 452 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 90.33% |
Latest transcript on Phathom Pharmaceuticals, Inc.
1 day | -5.54% | ||
1 week | +13.40% | ||
Current month | +13.40% | ||
1 month | -7.83% | ||
3 months | +41.63% | ||
6 months | +26.11% | ||
Current year | +12.16% |
Managers | Title | Age | Since |
---|---|---|---|
Azmi Nabulsi
FOU | Founder | 64 | 18-01-08 |
Terrie Curran
CEO | Chief Executive Officer | 55 | 19-07-31 |
David Socks
FOU | Founder | 49 | 18-01-08 |
Members of the board | Title | Age | Since |
---|---|---|---|
Heidi Fields
BRD | Director/Board Member | 69 | 19-09-26 |
Frank Karbe
BRD | Director/Board Member | 55 | 22-04-24 |
Michael Cola
CHM | Chairman | 64 | 19-09-26 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.02% | 0 M€ | 0.00% | - | |
0.02% | 0 M€ | 0.00% | - | |
0.02% | 0 M€ | -.--% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-07 | 10.24 | -5.54% | 533,650 |
24-05-06 | 10.84 | +7.97% | 698,082 |
24-05-03 | 10.04 | +2.87% | 647,444 |
24-05-02 | 9.76 | +5.40% | 1,082,510 |
24-05-01 | 9.26 | +2.55% | 512,297 |
Delayed Quote Nasdaq, May 07, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+12.16% | 634M | |
+21.74% | 46.81B | |
-0.97% | 41.37B | |
+47.07% | 41.29B | |
-3.52% | 28.87B | |
+11.12% | 26.06B | |
-19.37% | 19.13B | |
+31.18% | 12.39B | |
-0.04% | 12.08B | |
+0.39% | 11.96B |
- Stock Market
- Equities
- PHAT Stock